Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

Adjusted EBITDA of $66.5 million, or 27.0% of revenue, in the comparable period in 2010.  

GAAP net income (before noncontrolling interest) for the third quarter of 2011 was $6.3 million compared to GAAP net income of $6.6 million for the same period in 2010.  GAAP net income per diluted share for the third quarter of 2011 was $0.04 for both the third quarter of 2011 and 2010.  Non-GAAP Adjusted Net Income per fully diluted share for the third quarter of 2011 was $0.26, using a weighted average fully diluted share count of 124.2 million, compared to $0.23, using a weighted average fully diluted share count of 122.6 million, for the same period in 2010.

A reconciliation of Emdeon's financial results determined in accordance with U.S. Generally Accepted Accounting Principles (GAAP) to certain non-GAAP financial measures has been provided in the financial statement tables included in this release to supplement its unaudited condensed consolidated financial statements presented on a GAAP basis.  An explanation of these non-GAAP measures is also included below under the heading "Explanation of Non-GAAP Financial Measures."

Conference Call and WebcastAs noted in an earlier release, a fund managed by Blackstone on behalf of its private equity investors has completed its acquisition of Emdeon on November 2, 2011.  As a result, Emdeon will not host a conference call to discuss financial results for the third quarter of 2011.  

About EmdeonEmdeon is a leading provider of revenue and payment cycle management and clinical information exchange solutions, connecting payers, providers and patients in the U.S. healthcare system.  Emdeon's offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter.  Through the use of Emdeon's comprehensive suite of solutions, which are designed to easily integrate with existing technol
'/>"/>

SOURCE Emdeon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Conn. , Aug. 27, 2014  UBM Medica ... a leading online community for medical imaging professionals, presents ... Association for Medical Imaging Management,s 2014 Annual Meeting . ... conference coverage: , 11 Principles of ... can lead to greater profitability. , Why ...
(Date:8/27/2014)... 2014 Ambit Biosciences (Nasdaq: AMBI ), a ... unmet needs in oncology, autoimmune and inflammatory disease, today announced ... to be held at The New York Palace Hotel in ... 2014. Alan Fuhrman , Ambit,s CFO, will ... candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September 3, ...
(Date:8/27/2014)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... scheduled to make an investor presentation at the Robert W. ... on Wednesday, September 3, in New York City.  ... be available in the Investors section of the IRIDEX website ... IRIDEX Corporation was founded in 1989 and is a ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... December 13, 2011 -- Breadth of ... Pieris AG presented novel preclinical in ... its PRS-080 Anticalin hepcidin antagonist in an oral presentation ... company announced today.  In a presentation entitled "Discovery and ...
... 13, 2011 Cell Therapeutics, Inc. ("CTI") (NASDAQ: ... Ltd. announced that final results from the phase II ... or refractory acute myeloid leukemia (AML) were presented by ... Anderson Cancer Center during the Acute Myeloid Leukemia - ...
Cached Medicine Technology:Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at ASH Annual Meeting 2Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at ASH Annual Meeting 3Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 2Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 3Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 4
(Date:8/27/2014)... Georgia State University’s Center for ... $600,000 grant from the Maternal and Child Health ... to support implementation of the Autism Plan for ... youth with autism spectrum disorder. , In preparing ... Advisory Council composed of key stakeholders from across ...
(Date:8/27/2014)... especially when your infant looks at you and babbles. ... by listening and responding, they let their infants know ... sounds and using language more quickly. , That,s according ... and Indiana University that found how parents respond to ... communicate and use vocalizations. , The findings challenge the ...
(Date:8/27/2014)... For nearly two decades, audiences around the world ... Deva Premal & Miten with their rapturous Nepali flute ... album in May, their 2014 MANTRAS FOR LIFE TOUR ... globe, including Russia, Ukraine, Israel, Australia, the U.S., Canada, ... new album and a new five-piece band, the love ...
(Date:8/27/2014)... 27, 2014 The American Brain ... of the 2014-2016 Basic Research Fellowships and 2014-2015 Discovery ... the ABTA is seeding the field with talented, bright ... understanding of the causes, effects, diagnosis and treatment of ... scientific committee based on the potential to advance the ...
(Date:8/27/2014)... While many scientists are trying to prevent the ... autophagy, researchers at Virginia Commonwealth University Massey Cancer ... that causes the process to culminate in cell ... targets the p62 protein, which is often referred ... role in disposing unwanted cellular proteins during autophagy. ...
Breaking Medicine News(10 mins):Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2Health News:Parents, listen next time your baby babbles 2Health News:Parents, listen next time your baby babbles 3Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2
... already known to predict heart disease may also indicate ... a new Johns Hopkins study. ,C-reactive protein, or ... of CRP have been linked to higher risks of ... and diabetes. Researshers hypothesized that inflammation could play a ...
... legs syndrome is an irritating feeling of uneasiness, tiredness and ... can be painful // and often worsen at night. ... called restless legs syndrome. Studies on restless legs syndrome are ... to look at the prevalence and factors related to restless ...
... source of radiation exposure to the general population. Although ... also believed exposure during the test is responsible for ... to calculate the risk of cancer from exposure to ... and Cancer Research in the United Kingdom conducted the ...
... blood may predict the risk of heart attack or death ... new study. ,Researchers conducted a study to determine whether ... for death or non-fatal heart attack in patients with acute ... factor family and it acts as an instigator of hardening ...
... cancer accounts for the largest number of new cancer ... an international study found the survival rate of non-small-cell ... adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that interferes ... growth and spread in the body. ,As ...
... percent of diabetics take the proper preventative measures ... Researchers stressed continued negligence by diabetics increases their ... coronary heart disease, stroke, and lower extremity amputations. ... years or older, who had been diagnosed with ...
Cached Medicine News:Health News:Blood Marker Found To Predict Colon Cancer 2
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: